Business Context and Reporting Period
This Form 8-K is a current report filed by Synta Pharmaceuticals Corp. (not Madrigal Pharmaceuticals, Inc., as indicated in the metadata) on April 14, 2008. The report discloses a change in the company's independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the administrative change of auditors.
Material Changes Versus Prior Period
- Dismissal of Auditor: On April 14, 2008, the Audit Committee dismissed KPMG LLP, which had served as the independent auditor for the fiscal years ended December 31, 2006, and 2007.
- Engagement of New Auditor: On the same date, the Audit Committee engaged Ernst & Young LLP as the independent registered accounting firm for the fiscal year ending December 31, 2008.
- Audit Opinion Status: KPMG's reports for 2006 and 2007 did not contain adverse opinions, disclaimers, or qualifications regarding uncertainty, audit scope, or accounting principles. The only modification was a separate paragraph noting the adoption of SFAS No. 123R (Share-Based Payment) effective January 1, 2006.
Guidance, Outlook, Risks, and Contingencies
The filing states that during the "Relevant Period" (fiscal years 2006-2007 and the interim period through April 14, 2008), there were no "disagreements" or "reportable events" between Synta and KPMG regarding accounting principles, financial statement disclosure, or auditing scope. Additionally, Synta confirmed that no consultations were held with Ernst & Young LLP regarding accounting principles or reportable events prior to their engagement.
Important Facts for Investor Verification
- Verify the content of the letter from KPMG LLP (Exhibit 16.1) to confirm they agree with Synta's statements regarding the absence of disagreements.
- Confirm the effective date of the transition to Ernst & Young LLP for the 2008 fiscal year.
- Review the company's subsequent filings to ensure the new auditor's initial reports do not reveal previously undisclosed issues.